Stock HRTX HERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Heron Therapeutics, Inc.

Equities

HRTX

US4277461020

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
2.45 USD -3.92% Intraday chart for Heron Therapeutics, Inc. -7.20% +44.12%
Apr. 23 Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target MT
Mar. 21 Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
PR
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
PR
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
PR
Heron Therapeutics : Q4 2023 Earnings Call Presentation
PU
Heron Therapeutics : Q4 2023 Earnings Call Presentation
PU
Heron Therapeutics: Q4 Earnings Snapshot
AQ
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
PR
Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
PR
Heron Therapeutics Announces FDA Approval of ZYNRELEF Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
AQ
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
PR
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
AQ
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
PR
Heron Therapeutics: Q3 Earnings Snapshot
AQ
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
PR
Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023
PR
Biotech Stocks: Exciting Breakthroughs and Emerging Trends to Watch - INBS, HUMA, HRTX, HALB, RMED
AQ
Heron Therapeutics : Q2 2022 Earnings Call Presentation
PU
Heron Therapeutics: Q2 Earnings Snapshot
AQ
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
PR
Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRTX Stock
  4. News Heron Therapeutics, Inc.
  5. Press Releases